Analyst consensus rating
Crinetics Pharmaceuticals Analyst Rating: Hold
Direct answer
Crinetics Pharmaceuticals's consensus rating is Hold.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $85.00.
Forecast evidence checked September 5, 2026.
Get free Crinetics Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $84.95
- Average price target
- $85.00
- High price target
- $85.00
- Low price target
- $85.00
- Low target gap
- +0.1%
- Target upside
- +0.1%
- High target gap
- +0.1%
- Target range width
- 0%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals has a verified Hold consensus. The same dataset has an average price target of $85.00.
How far are Crinetics Pharmaceuticals's low and high targets from the recorded price?
The low target implies +0.1%, while the high target implies +0.1%.
How many analysts are included in Crinetics Pharmaceuticals's consensus?
The verified consensus includes 8 analysts.
How is Crinetics Pharmaceuticals's target upside or downside calculated?
The average target of $85.00 is divided by the recorded price of $84.95, then one is subtracted to produce +0.1%. This does not guarantee a future return.
When was Crinetics Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.